Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES ☑ NO ☐

Indicate by checkmark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (section 229.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).☑ Yes ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange ~~Act.~~Act ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES ☐ NO ☑

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date:

SONO-TEK CORPORATION

INDEX

	Page
Part I - Financial Information

Item 1 – Condensed Consolidated Financial Statements:	1 - 53

Condensed Consolidated Balance Sheets – ~~August 31,~~November 30, 2019 (Unaudited) and February 28, 2019	1

Condensed Consolidated Statements of Operations – ~~Six~~Nine and Three Months Ended ~~August 31,~~November 30, 2019 and 2018 (Unaudited)	2

Condensed Consolidated Statements of ~~Stockholders’~~Stockholders Equity – ~~Six~~Nine and Three Months Ended ~~August 31,~~November 30, 2019 and 2018 (Unaudited)	3

Condensed Consolidated Statements of Cash Flows – ~~Six~~Nine Months Ended ~~August 31,~~November 30, 2019 and 2018 (Unaudited)	54

Notes to Condensed Consolidated Financial ~~Statements6~~Statements	6~~- 11~~5- 9

Item 2 - Management's Discussion and Analysis of Financial Condition and Results of Operations	12~~–18~~10–16

Item 3 – Quantitative and Qualitative Disclosures about Market Risk	1917

Item 4 – Controls and Procedures	1917

Part II - Other Information	2018

Signatures and Certifications	2119

SONO-TEK CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

	August 31,						November 30,
	2019			February 28,			2019			February 28,
	(Unaudited)			2019			(Unaudited)			2019
ASSETS

Current Assets:
Cash and cash equivalents	$	2,280,981		$	3,144,123		$	2,279,506		$	3,144,123
Marketable securities		3,417,604			2,365,706			3,739,935			2,365,706
Accounts receivable (less allowance of $46,000)		1,272,400			1,397,891			1,338,320			1,397,891
Inventories, net		2,578,914			1,658,016			2,978,780			1,658,016
Prepaid expenses and other current assets		182,364			395,005			193,552			395,005
Total current assets		9,732,263			8,960,741			10,530,093			8,960,741

Land		250,000			250,000			250,000			250,000
Buildings, net		1,692,699			1,731,547			1,673,275			1,731,547
Equipment, furnishings and building improvements, net		976,939			802,932			975,835			802,932
Intangible assets, net		114,860			122,941			110,453			122,941
Deferred tax asset		332,017			332,017			332,017			332,017

TOTAL ASSETS	$	13,098,778		$	12,200,178		$	13,871,673		$	12,200,178

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current Liabilities:
Accounts payable	$	797,512		$	585,694		$	919,455		$	585,694
Accrued expenses		773,012			632,706			767,971			632,706
Customer deposits		1,584,452			1,149,558			1,953,826			1,149,558
Current maturities of long term debt		166,160			162,816			167,929			162,816
Income taxes payable		14,744			6,272			24,744			6,272
Total current liabilities		3,335,880			2,537,046			3,833,925			2,537,046

Deferred tax liability		370,757			370,757			370,757			370,757
Long term debt, less current maturities		623,676			707,715			581,065			707,715
Total liabilities		4,330,313			3,615,518			4,785,747			3,615,518

Commitments and Contingencies – (Note 10)		—			—
Commitments and Contingencies (Note 10)								—			—

Stockholders’ Equity
Common stock, $.01 par value; 25,000,000 shares authorized, 15,301,613 and 15,197,563 shares issued and outstanding, at August 31 and February 28, respectively		153,016			151,976
Common stock, $.01 par value; 25,000,000 shares authorized, 15,323,831 and 15,197,563 shares issued and outstanding, at November 30 and February 28, respectively								153,238			151,976
Additional paid-in capital		8,972,394			8,929,607			9,009,979			8,929,607
Accumulated deficit		(356,945	)		(496,923	)		(77,291	)		(496,923	)
Total stockholders’ equity		8,768,465			8,584,660			9,085,926			8,584,660

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$	13,098,778		$	12,200,178		$	13,871,673		$	12,200,178

See notes to unaudited condensed consolidated financial statements.

SONO-TEK CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	Six Months Ended August 31,						Three Months Ended August 31,						Nine Months Ended November 30,						Three Months Ended November 30,
	2019			2018			2019			2018			2019			2018			2019			2018

Net Sales	$	6,168,250		$	5,518,591		$	3,345,822		$	2,817,731		$	9,840,536		$	8,673,849		$	3,672,286		$	3,155,258
Cost of Goods Sold		3,316,323			2,902,949			1,798,830			1,473,286			5,191,929			4,761,919			1,875,606			1,858,970
Gross Profit		2,851,927			2,615,642			1,546,992			1,344,445			4,648,607			3,911,930			1,796,680			1,296,288

Operating Expenses
Research and product development costs		658,870			653,764			321,697			319,898			1,020,299			978,733			361,429			324,969
Marketing and selling expenses		1,476,696			1,326,701			799,284			696,913			2,326,115			1,979,365			849,419			652,664
General and administrative costs		619,475			589,200			333,662			313,808			935,693			857,832			316,218			268,632
Total Operating Expenses		2,755,041			2,569,665			1,454,643			1,330,619			4,282,107			3,815,930			1,527,066			1,246,265

Operating Income		96,886			45,977			92,349			13,826			366,500			96,000			269,614			50,023

Interest Expense		(17,465	)		(20,817	)		(8,518	)		(10,203	)		(25,465	)		(30,501	)		(8,000	)		(9,684	)
Interest and Dividend Income		56,983			71,522			25,812			36,916			77,496			104,686			20,513			33,164
Realized gain (loss) on sale of marketable securities		—			119,075			—			89,683
Realized gain on sale of marketable securities														—			119,075			—			—
Net unrealized loss on marketable securities		—			(129,657	)		—			(80,596	)		—			(189,016	)		—			(59,359	)
Other income (expense)		16,877			19,515			12,122			16,995
Other income														24,404			28,196			7,527			8,681

Income Before Income Taxes		153,281			105,615			121,765			66,621			442,935			128,440			289,654			22,825

Income Tax Expense		13,303			25,061			7,000			7,497			23,303			27,627			10,000			2,566

Net Income	$	139,978		$	80,554		$	114,765		$	59,124		$	419,632		$	100,813		$	279,654		$	20,259

Basic Earnings Per Share	$	0.01		$	0.01		$	0.01		$	0.00		$	0.03		$	0.01		$	0.02		$	0.00

Diluted Earnings Per Share	$	0.01		$	0.01		$	0.01		$	0.00		$	0.03		$	0.01		$	0.02		$	0.00

Weighted Average Shares - Basic		15,285,024			15,036,644			15,301,613			15,085,660			15,291,968			15,078,933			15,306,008			15,164,440

Weighted Average Shares - Diluted		15,376,906			15,169,210			15,399,163			15,224,221			15,354,472			15,284,071			15,371,819			15,386,094

See notes to unaudited condensed consolidated financial statements.

SONO-TEK CORPORATION

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

~~SIX~~NINE AND THREE MONTHS ENDED ~~AUGUST 31,~~NOVEMBER 30, 2019 AND 2018

~~Six~~Nine Months Ended ~~August 31,~~November 30, 2019 and 2018

								Accumulated
	Common Stock				Additional			Other					Total
	Par Value $.01				Paid – In			Comprehensive		Accumulated			Stockholders’
	Shares		Amount		Capital			Income (Loss)		Deficit			Equity		Common Stock Par Value $.01				Additional Paid – In			Accumulated Other Comprehensive			Accumulated			Total Stockholders’
															Shares		Amount		Capital			Income (Loss)			Deficit			Equity
Balance – February 28, 2019		15,197,563	$	151,976	$	8,929,607		$	—	$	(496,923	)	$	8,584,660		15,197,563	$	151,976	$	8,929,607		$	—		$	(496,923	)	$	8,584,660
Cashless exercise of stock options		104,050		1,040		(1,040	)									126,268		1,262		(1,262	)								—
Stock based compensation expense						43,827								43,827						81,634									81,634
Net Income											139,978			139,978												419,632			419,632
Balance – August 31, 2019 (unaudited)		15,301,613	$	153,016	$	8,972,394		$	—	$	(356,945	)	$	8,768,465
Balance – November 30, 2019 (unaudited)																15,323,831	$	153,238	$	9,009,979		$	—		$	(77,291	)	$	9,085,926

Balance – February 28, 2018																14,986,367	$	149,864	$	8,901,171		$	101,605		$	(760,115	)	$	8,392,525
Reclassification of unrealized gain on marketable securities upon adoption of ASU 2016-01																							(101,605	)		101,605			—
Cashless exercise of stock options																205,358		2,054		(2,054	)								—
Stock based compensation expense																				22,777									22,777
Net income																										100,813			100,813
Balance – November 30, 2018 (unaudited)																15,191,725	$	151,918	$	8,921,894		$	—		$	(557,697	)	$	8,516,115

Common Stock
Par Value $.01
Additional
Paid – In Accumulated Other Comprehensive Accumulated Total Stockholders’
Shares Amount Capital Income (Loss) Deficit Equity
Balance – February 28, 2018 14,986,367 $ 149,864 $ 8,901,171 $ 101,605 $ (760,115 ) $ 8,392,525
Reclassification of unrealized gain on marketable securities upon adoption of ASU 2016-01 (101,605 ) 101,605 —
Cashless exercise of stock options 169,193 1,692 (1,692 ) —
Stock based compensation expense 16,394 16,394
Net Income 80,554 80,554
Balance – August 31, 2018 (Unaudited) 15,155,560 $ 151,556 $ 8,915,873 $ — $ (577,956 ) $ 8,489,473

~~Three Months Ended August 31, 2019 and 2018~~

Common Stock
Par Value $.01
Additional
Paid – In Accumulated Other Comprehensive Accumulated Total Stockholders’
Shares Amount Capital Income (Loss) Deficit Equity
Balance – June 1, 2019 15,301,613 $ 153,016 $ 8,939,877 — $ (471,710 ) $ 8,621,183
Stock based compensation expense 32,517 32,517
Net Income 114,765 114,765
Balance – August 31, 2019 (Unaudited) 15,301,613 $ 153,016 $ 8,972,394 $ — $ (356,945 ) $ 8,768,465

Common Stock
Par Value $.01
Additional
Paid – In Accumulated
Other Comprehensive Accumulated Total Stockholders’
Shares Amount Capital Income (Loss) Deficit Equity
Balance – June 1, 2018 14,989,003 $ 149,890 $ 8,910,045 — $ (637,080 ) $ 8,422,855
Cashless exercise of stock options 166,557 1,666 (1,666 ) —
Stock based compensation expense 7,494 7,494
Net Income 59,124 59,124
Balance – August 31, 2018 (Unaudited) 15,155,560 $ 151,556 $ 8,915,873 $ — $ (577,956 ) $ 8,489,473

Three Months Ended November 30, 2019 and 2018
	Common Stock Par Value $.01				Additional Paid – In			Accumulated Other Comprehensive		Accumulated			Total Stockholders’
	Shares		Amount		Capital			Income (Loss)		Deficit			Equity
Balance – August 31, 2019 (unaudited)		15,301,613	$	153,016	$	8,972,394		$	—	$	(356,945	)	$	8,768,465
Cashless exercise of stock options		22,218		222		(222	)							—
Stock based compensation expense						37,807								37,807
Net income											279,654			279,654
Balance – November 30, 2019 (unaudited)		15,323,831	$	153,238	$	9,009,979		$	—	$	(77,291	)	$	9,085,926

Balance – August 31, 2018 (unaudited)		15,155,560	$	151,556	$	8,915,873		$	—	$	(577,956	)	$	8,489,473
Cashless exercise of stock options		36,165		362		(362	)							—
Stock based compensation expense						6,383								6,383
Net income											20,259			20,259
Balance – November 30, 2018 (unaudited)		15,191,725	$	151,918	$	8,921,894		$	—	$	(557,697	)	$	8,516,115

See notes to unaudited condensed consolidated financial statements.

SONO-TEK CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	Unaudited
	Six Months Ended August 31,						Unaudited
	2019			2018			Nine Months Ended November 30,
							2019			2018
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income	$	139,978		$	80,554		$	419,632		$	100,813
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		191,977			172,130			290,203			256,519
Stock based compensation expense		43,827			16,394			81,634			22,777
Inventory reserve		32,000			36,000			50,000			48,000
Unrealized loss on marketable securities		—			129,657			—			189,016
Decrease (Increase) in:
Accounts receivable		125,491			(518,699	)		59,571			(388,538	)
Inventories		(952,898	)		(332,704	)		(1,370,764	)		(436,802	)
Prepaid expenses and other current assets		212,642			24,682			201,453			(150,391	)
(Decrease) Increase in:
Accounts payable and accrued expenses		352,124			71,845			469,026			(99,748	)
Customer Deposits		434,894			88,398			804,268			620,303
Income taxes payable		8,472			(76,365	)		18,472			(73,800	)
Net Cash Provided by (Used In) Operating Activities		588,507			(308,108	)
Net Cash Provided by Operating Activities								1,023,495			88,149

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of equipment and furnishings		(319,055	)		(159,790	)		(392,346	)		(486,711	)
Sale (purchase) of marketable securities		(1,051,898	)		184,249			(1,374,229	)		125,534
Net Cash (Used in) Provided by Investing Activities		(1,370,953	)		24,459
Net Cash Used in Investing Activities								(1,766,575	)		(361,177	)

CASH FLOWS FROM FINANCING ACTIVITIES:
Repayment of long term debt		(80,696	)		(77,410	)		(121,537	)		(116,555	)
Net Cash (Used In) Financing Activities		(80,696	)		(77,410	)
Net Cash Used In Financing Activities								(121,537	)		(116,555	)

NET DECREASE IN CASH AND CASH EQUIVALENTS		(863,142	)		(361,059	)		(864,617	)		(389,583	)

CASH AND CASH EQUIVALENTS
Beginning of period		3,144,123			2,016,464			3,144,123			2,016,464
End of period	$	2,280,981		$	1,655,405		$	2,279,506		$	1,626,881

SUPPLEMENTAL CASH FLOW DISCLOSURE:
Interest paid	$	17,465		$	20,817		$	25,465		$	30,501
Income Taxes Paid	$	4,831		$	101,426		$	4,831		$	101,426

See notes to unaudited condensed consolidated financial statements.

SONO-TEK CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

~~SIX~~NINE MONTHS ENDED ~~AUGUST 31,~~November 30, 2019 and 2018

(Unaudited)

NOTE 1: BUSINESS DESCRIPTION

Sono-Tek Corporation (the “Company”, “Sono-Tek”, “We” or “Our”) is the world leader in the design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to protect, strengthen or smooth surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. We design and manufacture custom-engineered ultrasonic coating systems and also provide patented nozzles and generators for manufacturers’ equipment.

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information. Accordingly, the Condensed Consolidated Financial Statements do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of the Company’s management, all adjustments considered necessary for a fair presentation (consisting of normal recurring adjustments) have been included. The results for the interim periods are not necessarily indicative of what the results will be for the fiscal year. The accompanying Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements as of and for the fiscal year ended February 28, 2019 (“fiscal year 2019”) contained in the Company’s 2019 Annual Report on Form 10-K filed with the SEC. The Company’s current fiscal year ends on February 29, 2020 (“fiscal 2020”).

NOTE 2: SIGNIFICANT ACCOUNTING POLICIES

Cash and Cash Equivalents - Cash and cash equivalents consist of money market mutual funds, short term commercial paper and short-term certificates of deposit with original maturities of 90 days or less.

Consolidation - The accompanying condensed consolidated financial statements of the Company, include the accounts of the Company and its wholly owned subsidiary, Sono-Tek Industrial Park, LLC (“SIP”). SIP operates as a real estate holding company for the Company’s real estate operations.

Earnings Per Share - Basic earnings per share (“EPS”) is computed by dividing net income by the weighted-average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock.

Equipment, Furnishings and Leasehold Improvements – Equipment, furnishings and leasehold improvements are stated at cost. Depreciation of equipment and furnishings is computed by use of the straight-line method based on the estimated useful lives of the assets, which range from three to five years.

Fair Value of Financial Instruments - The Company follows the guidance in the “Fair Value Measurements and Disclosure Topic” of the Accounting Standards Codification for assets and liabilities measured at fair value on a recurring basis. This guidance establishes a common definition for fair value to be applied to existing generally accepted accounting principles that require the use of fair value measurements, establishes a framework for measuring fair value and expands disclosure about such fair value measurements. The guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Additionally, the guidance requires the use of valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. These inputs are prioritized below:

Level 1: Quoted prices in active markets.

Level 2: Observable market-based inputs or unobservable inputs that are corroborated by market data.

Level 3: Unobservable inputs for which there is little or no market data, which require the use of the reporting entity’s own assumptions.

The fair values of financial assets of the Company were determined using the following categories at ~~August 31,~~November 30, 2019 and February 28, 2019, respectively:

Quoted Prices in Active Markets
(Level 1)
August 31,
2019 February 28,
2019

Marketable Securities $ 3,417,604 $ 2,365,706

	Quoted Prices in Active Markets
	(Level 1)
	November 30, 2019		February 28, 2019
Marketable Securities	$	3,739,935	$	2,365,706

Marketable Securities include mutual funds, certificates of deposit and US Treasury securities of ~~$3,417,604~~$3,739,935 and $2,365,706 that are considered to be highly liquid and easily tradeable as of ~~August 31,~~November 30, 2019, and February 28, 2019, respectively. These securities are valued using inputs observable in active markets for identical securities and are therefore classified as Level 1 within the Company’s fair value hierarchy. The Company’s marketable securities are considered to be available-for-sale investments as defined under ASC 320 “Investments – Debt and Equity Securities.”

Income Taxes - The Company accounts for income taxes under the asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences of "temporary differences" by applying enacted statutory tax rates applicable to future years to differences between the financial statement carrying amounts and the tax basis of existing assets and liabilities. If it is more likely than not that some portion or all of a deferred tax asset will not be realized, a valuation allowance is recognized.

Intangible Assets - Include costs of patent applications which are deferred and charged to operations over seventeen years for domestic patents and twelve years for foreign patents. The accumulated amortization of patents is ~~$165,832~~$168,516 and $160,433 at ~~August 31,~~November 30, 2019 and February 28, 2019, respectively. Annual amortization expense of such intangible assets is expected to be approximately $11,000 per year for the next five years.

Interim Reporting - The attached summary condensed consolidated financial information does not include all disclosures required to be included in a complete set of financial statements prepared in conformity with accounting principles generally accepted in the United States of America. Such disclosures were included with the financial statements of the Company at February 28, 2019, and included in its report on Form 10-K. Such statements should be read in conjunction with the data herein.

The financial information reflects all adjustments, normal and recurring, which, in the opinion of management, are necessary for a fair presentation of the results for the interim periods presented. The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The results for such interim periods are not necessarily indicative of the results to be expected for the year.

Inventories - Inventories are stated at the lower of cost or market. Cost is determined using the first-in, first-out (FIFO) method for raw materials, subassemblies and work-in-progress and the specific identification method for finished goods.

Land and Buildings – Land and buildings are stated at cost. Buildings are being depreciated by use of the straight-line method based on an estimated useful life of forty years.

Long-Lived Assets - The Company periodically evaluates the carrying value of long-lived assets, including intangible assets, when events and circumstances warrant such a review. The carrying value of a long-lived asset is considered impaired when the anticipated undiscounted cash flow from such asset is separately identifiable and is less than its carrying value. In that event, a loss is recognized based on the amount by which the carrying value exceeds the fair market value of the long-lived asset. Fair market value is determined primarily using the anticipated cash flows discounted at a rate commensurate with the risk involved.

Management Estimates - The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Marketable Securities - The Company adopted ASU 2016-01, “Financial Instruments – Overall: Recognition and Measurement of Financial Assets and Financial Liabilities.” ASU 2016-01 requires equity investments (except those accounted for under the equity method of accounting, or those that result in consolidation of the investee) to be measured at fair value with changes in fair value recognized in net income, requires public business entities to use the exit price notion when measuring the fair value of financial instruments for disclosure purposes, requires separate presentation of financial assets and financial liabilities by measurement category and form of financial asset, and eliminates the requirement for public business entities to disclose the method(s) and significant assumptions used to estimate the fair value that is required to be disclosed for financial instruments measured at amortized cost. The Company has evaluated the potential impact this standard may have on the condensed consolidated financial statements and the fair value allowance of the securities from the prior year has been reclassified to Retained Earnings from Other Accumulated Comprehensive Income. The unrealized loss on the marketable securities during the three and ~~six~~nine months ended ~~August 31,~~November 30, 2018 has been disclosed a separate line item on the Income Statement.

New Accounting Pronouncements-

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), to increase transparency and comparability among organizations by recognizing a right-of-use asset and a lease liability on the balance sheet for all leases with terms longer than 12 months. Leases will be classified as either operating or financing, with such classification affecting the pattern of expense recognition in the income statement. ASU 2016-02 is effective for fiscal years and interim periods within those years beginning after December 15, 2018, and early adoption is permitted. The adoption of ASU 2016-02 had no material impact on the Company’s financial statements.

In February 2018, the FASB issued ASU 2018-02, Income Statement - Reporting Comprehensive Income (Topic 220), “Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income”. ASU 2018-02 was issued to allow the reclassification from accumulated other comprehensive income to retained earnings for the stranded tax effect resulting from the Tax Cuts and Jobs Act enacted on December 22, 2017. The Tax Cuts and Jobs Act, among other things, reduced the corporate tax rate from 35% to 21%, which required the re-evaluation of any deferred tax assets and liabilities at the lowered tax rate which potentially could leave a disproportionate tax effect in accumulated other comprehensive income. ASU 2018-02 allows for the election to reclassify these stranded tax effects to retained earnings. ASU 2018-02 is effective for all entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years. Early adoption is permitted, including adoption in any interim period for public business entities for reporting periods for which financials statements have not yet been issued. The adoption of ASU 2018-02 had no material impact on the Company’s financial statements.

Other than Accounting Standards Update (“ASU”) ASU 2016-02 and ASU 2018-02 discussed above, all new accounting pronouncements issued but not yet effective have been deemed to be not applicable to the Company. Hence, the adoption of these new accounting pronouncements, once effective, is not expected to have an impact on the Company.

Reclassifications – Where appropriate, certain reclassifications have been made to the prior period to conform to the presentations of the current period.

NOTE 3: REVENUE RECOGNITION

In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers” (Topic 606), to clarify the principles of recognizing revenue and create common revenue recognition guidance between U.S. GAAP and International Financial Reporting Standards. Under ASU 2014-09, revenue is recognized when a customer obtains control of promised goods or services and is recognized at an amount that reflects the consideration expected to be received in exchange for such goods or services. In addition, ASU 2014-09 requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The ASU is effective for fiscal years beginning after December 15, 2017.

The new revenue standard is principle based and interpretation of those principles may vary from company to company based on their unique circumstances. It is possible that interpretation, industry practice, and guidance may evolve as companies and the accounting profession work to implement this new standard. The implementation of the standard did not have a material impact on the financial statements.

A majority of the Company’s sales revenue is derived primarily from short term contracts with customers, which, on average, are in effect for less than twelve months. Sales revenue from manufactured equipment transferred at a single point in time accounts for a majority of the Company’s revenue.

Sales revenue is recognized when control of the Company’s manufactured equipment is transferred to its customers, in an amount that reflects the consideration the Company expects to receive based upon the agreed transaction price. The Company’s performance obligations are satisfied when its customers take control of the purchased equipment, which is based on the contract terms. Based on prior experience, the Company reasonably estimates its sales returns and warranty reserves. Sales are presented net of discounts and allowances. Discounts and allowances are determined when a sale is negotiated. The Company does not grant its customers or independent representatives, the ability to return equipment nor does it grant price adjustments after a sale is complete.

The Company does not capitalize any sales commission costs related to the acquisition of a contract. All commissions related to a performance obligation that are satisfied at a point in time are expensed when the customer takes control of the purchased equipment.

At ~~August 31,~~November 30, 2019, the Company had received ~~$1,584,000~~$1,954,000 in cash deposits, and had issued Letters of Credit in the amount of $659,000 to secure these cash deposits. The Company was utilizing $659,000 of its available credit line to collateralize these letters of credit. The Company’s inventory included approximately ~~$739,000~~$707,000 directly related to servicing these customer contracts.

NOTE 4: INVENTORIES

Inventories consist of the following:

	August 31,			February 28,			November 30,			February 28,
	2019			2019			2019			2019
Raw materials and subassemblies	$	862,495		$	873,483		$	1,050,183		$	873,483
Finished goods		573,923			571,640			598,218			571,640
Contracts in process inventory		739,471			—			706,582			—
Work in process		563,305			483,271			802,077			483,271
Total		2,739,194			1,928,394			3,157,060			1,928,394
Less: Allowance		(160,280	)		(270,378	)		(178,280	)		(270,378	)
Net inventories	$	2,578,914		$	1,658,016		$	2,978,780		$	1,658,016

NOTE 5: STOCK OPTIONS

Stock Options – Under the 2013 Stock Incentive Plan ("2013 Plan"), options can be granted to officers, directors, consultants and employees of the Company and its subsidiaries to purchase up to 2,500,000 shares of the Company's common stock. Under the 2013 Plan options expire ten years after the date of grant. As of ~~August 31,~~November 30, 2019, there were ~~475,834~~546,667 options outstanding under the 2013 Plan.

Under the 2003 Stock Incentive Plan, as amended ("2003 Plan"), until May 2013, options were available to be granted to officers, directors, consultants and employees of the Company and its subsidiaries to purchase up to 1,500,000 shares of the Company's common stock. As of ~~August 31,~~November 30, 2019, there were ~~80,000~~50,000 options outstanding under the 2003 Plan, under which no additional options may be granted.

During the ~~six~~nine months ended ~~August 31,~~November 30, 2019, ~~162,166~~228,833 options were exercised on a cashless basis into ~~104,050~~126,268 shares of common stock.

NOTE 6: STOCK BASED COMPENSATION

The Company adopted ASC 718, “Share Based Payments.” which requires companies to expense the value of employee stock options and similar awards.

During the three ~~and six~~ months ended ~~August 31,~~November 30, 2019, the Company granted options to acquire ~~10,000~~7,500 shares to employees exercisable at $2.10 and options for 100,000 shares to an officer with an exercise price of $2.65. The options granted to employees vest over three years and expire in ten years. The options granted to the officer vested upon grant and expire in ten years. All of the options granted by the Company during the three months ended November 30, 2019 had a combined weighted average grant date fair value of $0.32 per share.

During the nine months ended November 30, 2019, the Company granted options to acquire 17,500 shares to employees exercisable at prices ranging from $2.10 to $2.65, options to acquire 20,000 shares to the non-employee members of the board of directors with an exercise price of $2.65 and options for ~~100,000~~200,000 shares to an officer ~~with an exercise price~~and director exercisable at prices of ~~$2.45.~~ranging from $2.45 to $2.65. The options granted to employees and directors vest over three years and expire in ten years. The options granted to the officer vested upon grant and expire in ten years. ~~The~~All of the options granted by the Company during the nine months ended November 30, 2019 had a combined weighted average grant date fair value of ~~$0.35~~$0.34 per share.

The weighted-average fair value of options are estimated on the date of grant using the Black-Scholes options-pricing model. The weighted-average Black-Scholes assumptions are as follows:

	~~Six~~Nine Months Ended ~~August 31,~~November 30, 2019
Expected Life	1-8 years
Risk free interest rate	1.58% - 2.05%
Expected volatility	27.46% - ~~29.05%~~32.24%
Expected dividend yield	0%

In computing the impact, the fair value of each option is estimated on the date of grant based on the Black-Scholes options-pricing model utilizing certain assumptions for a risk free interest rate; volatility; and expected remaining lives of the awards. The assumptions used in calculating the fair value of share-based payment awards represent management’s best estimates, but these estimates involve inherent uncertainties and the application of management judgment. As a result, if factors change and the Company uses different assumptions, the Company’s stock-based compensation expense could be materially different in the future. In addition, the Company is required to estimate the expected forfeiture rate and only recognize expense for those shares expected to vest. In estimating the Company’s forfeiture rate, the Company analyzed its historical forfeiture rate, the remaining lives of unvested options, and the number of vested options as a percentage of total options outstanding. If the Company’s actual forfeiture rate is materially different from its estimate, or if the Company reevaluates the forfeiture rate in the future, the stock-based compensation expense could be significantly different from what the Company has recorded in the current period.

For the three and ~~six~~nine months ended ~~August 31,~~November 30, 2019 and 2018, net income and earnings per share reflect the actual deduction for stock-based compensation expense. The impact of applying ASC 718 approximated ~~$33,000~~$38,000 and $7,000 in additional compensation expense during the three months ended ~~August 31,~~November 30, 2019 and 2018, respectively. The impact of applying ASC 718 approximated ~~$44,000~~$82,000 and ~~$16,000~~$23,000 in additional compensation expense during the ~~six~~nine months ended ~~August 31,~~November 30, 2019 and 2018, respectively. Such amounts are included in general and administrative expenses on the statement of operations. The expense for stock-based compensation is a non-cash expense item.

NOTE 7: EARNINGS PER SHARE

The denominators for the calculation of diluted earnings per share at ~~August 31,~~November 30, 2019 and 2018 are calculated as follows:

	Six Months Ended August 31,				Three Months Ended August 31,				Nine Months Ended				Three Months Ended
	2019		2018		2019		2018		November 30,				November 30,
									2019		2018		2019		2018
Numerator for basic and diluted earnings per share	$	139,978	$	80,554	$	114,765	$	59,124	$	419,632	$	100,813	$	279,654	$	20,259

Denominator for basic earnings per share – weighted average		15,285,024		15,036,644		15,301,613		15,085,660		15,291,968		15,078,933		15,306,008		15,164,440

Effects of dilutive securities

Stock options for employees, directors and outside consultants		91,882		132,566		97,550		138,561		62,504		205,138		65,811		221,654

Denominator for diluted earnings per share		15,376,906		15,169,210		15,399,163		15,224,221		15,354,472		15,284,071		15,371,819		15,386,094

Basic earnings per share	$	0.01	$	0.01	$	0.01	$	0.00	$	0.03	$	0.01	$	0.02	$	0.00
Diluted earnings per share	$	0.01	$	0.01	$	0.01	$	0.00	$	0.03	$	0.01	$	0.02	$	0.00

NOTE 8: LONG TERM DEBT

Long-term debt consists of the following:

	August 31,		February 28,		November 30,		February 28,
	2019		2019		2019		2019

Note payable, bank, collateralized by land and buildings, payable in monthly installments of principal and interest of $16,358 through January 2024 with an interest rate of 4.15% and a 10-year term.	$	789,836	$	870,531	$	748,994	$	870,531

Total long term debt		789,836		870,531		748,994		870,531
Due within one year		166,160		162,816		167,929		162,816
Due after one year	$	623,676	$	707,715	$	581,065	$	707,715

NOTE 9: REVOLVING LINE OF CREDIT

The Company has a $1,500,000 revolving line of credit at prime which was ~~5.25%~~4.75% at ~~August 31,~~November 30, 2019. The revolving credit line is collateralized by the Company’s accounts receivable and inventory. The line of credit is payable on demand and must be retired for a 30-day period, once annually. If the Company fails to perform the 30-day annual pay down or if the bank elects to terminate the credit line, the bank may, at its option, convert the outstanding balance to a 36-month term note with payments including interest in 36 equal installments.

As of ~~August 31,~~November 30, 2019, $659,000 of the Company’s credit line was being utilized to collateralize letters of credit issued to customers that have remitted cash deposits to the Company on existing orders. The letters of credit expire in 2020. As of ~~August 31,~~November 30, 2019, there were no outstanding borrowings under the line of credit and the unused portion of the credit line was $841,000 as of ~~August 31,~~November 30, 2019.

NOTE 10: COMMITMENTS AND CONTINGENCIES

Other than the letters of credit disclosed in Note 9, the Company did not have any material commitments or contingencies as of ~~August 31,~~November 30, 2019.

NOTE 9:11: SUBSEQUENT EVENTS

The Company has evaluated subsequent events for disclosure purposes.

ITEM 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations

FORWARD-LOOKING STATEMENTS

We discuss expectations regarding our future performance, such as our business outlook, in our annual and quarterly reports, ~~press~~news releases, and other written and oral statements. These “forward-looking statements” are based on currently available competitive, financial and economic data and our operating plans. They are inherently uncertain, and investors must recognize that events could turn out to be significantly different from our ~~expectations.~~expectations and could cause actual results to differ materially. These factors include, among other considerations, general economic and business conditions; political, regulatory, tax, competitive ~~technological~~ and ~~trade barrier~~technological developments affecting our operations or the demand for our ~~products;~~products, including the imposition of tariffs; timely development and market acceptance of new ~~products;~~products and continued customer validation of our coating technologies; adequacy of financing; capacity ~~additions;~~additions, the ability to enforce patents; maintenance of operating leverage; maintenance of increased order backlog; consummation of order proposals; completion of ~~backlog during~~large orders on schedule and on budget; continued sales growth in the ~~current fiscal year~~medical and ~~the ability~~alternative energy markets; successful transition from primarily selling ultrasonic nozzles and components to ~~achieve increased sales volume at projected levels~~a more complex business providing complete machine solutions and ~~continued profitability.~~higher value subsystems; and realization of quarterly and annual revenues within forecasted range.

We undertake no obligation to update any forward-looking statement.

OVERVIEW

Founded in 1975, Sono-Tek Corporation designs and manufactures ultrasonic coating systems that apply precise, thin film coatings to a multitude of products for the microelectronics/electronics, alternative energy, medical and industrial markets, including specialized glass applications in construction and automotive. We also sell our products to emerging research and development and other markets. We have invested significant resources to enhance our market ~~diversity by leveraging~~diversity. Using our core ultrasonic coating ~~technology. As a result,~~technology, we have increased our portfolio of products, the industries we serve, and the countries in which we sell our products.

Our ultrasonic nozzle systems use high frequency, ultrasonic vibrations that atomize liquids into minute drops that can be applied to surfaces at low velocity providing thin layers of protective materials over a surface such as ~~glass or metals.~~glass. Our solutions are environmentally-friendly, efficient and highly reliable. They enable dramatic reductions in overspray, savings in raw material, water and energy usage and provide improved process repeatability, transfer efficiency, high uniformity and reduced emissions.

We believe product superiority is imperative in all that we produce and that it is ~~attained~~developed through the extensive experience we have in the coatings industry, our proprietary manufacturing know-how and skills and our unique work force we have built over the years. Our growth strategy is ~~to leverage~~focused on leveraging our innovative technologies, proprietary know-how, unique talent and experience, and global reach to further ~~advance the use of ultrasonic~~develop thin film coating technologies ~~for the microscopic coating of surfaces in a broader array of applications~~ that enable better outcomes for our customers’ products and processes.

We are a global business with approximately 65% of our sales generated from outside the United States ~~and Canada.~~in the first nine months of fiscal 2020. Our direct sales team and our distributor and sales representative network isare located in North America, Latin America, Europe and Asia. Over the last few years, we have expanded our sales capabilities by increasing the size of our direct sales force and adding new distributors and sales representatives (”(“reps”). ~~In addition,~~Of note, we have ~~established testing~~implemented demonstration labs atin several areas of Asia and Europe, in addition to our ~~distribution partner sites in China, Taiwan, Germany, Turkey, Korea and Japan, while also expanding our first testing~~headquarters lab ~~that is co-located with our manufacturing facilities~~ in New ~~York.~~York, that are used to train our distributors and reps. These labs ~~provide significant value~~are also valuable for demonstrating to prospective customers the capabilities of our equipment and ~~enabling~~enable us to develop custom solutions to meet their needs.

Over the last ~~decade,~~few years, we have shifted our business from primarily selling our ultrasonic nozzles and components to a more complex business providing complete machine solutions and higher value subsystems to original equipment manufacturers (“OEMs”). The range for our average unit selling price has ~~increased~~broadened as a result ~~from less than $8,000 for a nozzle and generator package~~ to ~~a range of~~ $50 thousand per unit to over $240 thousand per unit. As a result, ~~of this transition, we have broadened our addressable market and we believe that~~ we can ~~grow sales on a larger scale and we expect that we will~~ experience wide variations in both order flow and shipments from quarter to quarter.

~~Second~~Third Quarter Fiscal 2020 Highlights (compared with the ~~second~~third quarter of fiscal 2019 unless otherwise noted) We refer to the three-month periods ended ~~August 31,~~November 30, 2019 and 2018 as the ~~second~~third quarter of fiscal 2020 and fiscal 2019, respectively.

~~Net sales were $3,346,000, up 19% or $528,000, driven by increased sales of highly customized, multi axis coating systems to the Electronics/Microelectronics market.~~

~~Gross profit margin was 46.2% as compared to 47.7%. The decline in gross profit margin is primarily a result of product mix.~~

~~Operating income increased to $92,000, compared with operating income of $14,000. Growth in revenue and gross profit improved gross margin during the quarter.~~

Net sales were $3,672,000, up 16% or $517,000, primarily driven by increased sales for widetrack integrated coating systems in the float glass market, and increased sales of our SonoBraze product for the manufacturing of heat exchangers and condensers.

Gross profit margin was 48.9% compared with 41.1%. Improvement is primarily due to a shift in sales to countries other than China, change in product mix, and increased sales volume of integrated coating systems and multi-axis coating systems.

Operating income increased to $270,000, compared with operating income of $50,000. Growth in revenue and gross profit improved operating income during the quarter.

Backlog on ~~August 31,~~November 30, 2019 ~~was~~continues to be at record levels, up ~~37%~~78% to ~~$4,175,000,~~$5,402,000, compared with a backlog of $3,038,000 on February 28, ~~2019~~

2019.

~~First Half~~Nine Month Fiscal 2020 Highlights (compared with the first ~~half~~nine months of fiscal 2019 unless otherwise noted) We refer to the ~~six-month~~nine-month periods ended ~~August 31,~~November 30, 2019 and 2018 as the first ~~half~~nine months of fiscal 2020 and fiscal 2019, respectively.

Net sales were $6,168,000, up 12% or $649,000, driven primarily by demand from the Electronics/Microelectronics and Alternative Energy markets, as the effectiveness of our efforts to provide application engineering expertise and custom-designed complex coating solutions, of high customer value and greater selling price and increased revenue.

~~Gross profit margin was 46.2% as compared with 47.4% primarily as a result of changes in product mix.~~

~~Operating income increased to $97,000, compared with $46,000. Growth in revenue and gross profit were key factors in the improvement of operating income during the first half of fiscal 2020.~~

Net sales were $9,841,000, up 13% or $1,167,000, led by a large increase in sales to the semiconductor industry, increased sales of stent coating systems, and increased sales of float glass coating equipment.

Gross profit margin was 47.2% compared with 45.1%. Improvement is primarily due to a shift in sales to countries other than China, change in product mix, and increased sales volume of integrated coating systems and multi-axis coating systems.

Operating income increased to $367,000 compared with $96,000. Growth in revenue and gross profit were key factors in the improvement of operating income during the quarter.

RESULTS OF OPERATIONS

~~Sales:~~Sales

Product ~~Sales~~Sales:

Three Months Ended
August 31, Change Six Months Ended
August 31, Change
2019 2018 $ % 2019 2018 $ %
Fluxing Systems $ 211,000 $ 233,000 (22,000 ) (9% ) $ 602,000 $ 573,000 29,000 5%
Integrated Coating Systems 413,000 283,000 130,000 46% 810,000 631,000 179,000 28%
Multi-Axis Coating Systems 1,815,000 1,270,000 545,000 43% 2,888,000 2,132,000 756,000 35%
OEM Systems 246,000 527,000 (281,000 ) (53% ) 565,000 978,000 (413,000 ) (42% )
Other 661,000 505,000 156,000 31% 1,303,000 1,205,000 98,000 8%
TOTAL $ 3,346,000 $ 2,818,000 528,000 19% $ 6,168,000 $ 5,519,000 649,000 12%

	Three Months Ended November 30,				Change						Nine Months Ended November 30,				Change
	2019		2018		$			%			2019		2018		$			%
Fluxing Systems	$	261,000	$	281,000		(20,000	)		(7%	)	$	863,000	$	854,000		9,000			1%
Integrated Coating Systems		628,000		286,000		342,000			120%			1,438,000		917,000		521,000			57%
Multi-Axis Coating Systems		1,631,000		1,681,000		(50,000	)		(3%	)		4,519,000		3,813,000		706,000			19%
OEM Systems		400,000		402,000		(2,000	)		—			965,000		1,380,000		(415,000	)		(30%	)
Other		752,000		505,000		247,000			49%			2,056,000		1,710,000		346,000			20%
TOTAL	$	3,672,000	$	3,155,000		517,000			16%		$	9,841,000	$	8,674,000		1,167,000			13%

Sales growth was driven by demand for our more complex, highly-engineered and higher value multi-axis and integrated coating machines, primarily for the Electronics/Microelectronics and ~~Alternative Energy~~Medical markets in in the first ~~six~~nine months of fiscal 2020. This equipment’s average selling price can range from $100 thousand to over $300 thousand per unit and is typically ordered in one-or two-unit volumes. Growth in these product categories more than offset the decline in OEM Systems, greatly influenced by ~~a dip in sales~~our strategy to ~~several China based~~offer customers full coating solutions at higher price points compared to smaller revenue OEM ~~partners.~~packages.

Market ~~Sales~~Sales:

Three Months Ended
August 31, Change Six Months Ended
August 31, Change
2019 2018 $ % 2019 2018 $ %
Electronics/Microelectronics $ 1,376,000 $ 685,000 691,000 100% $ 2,913,000 $ 2,014,000 899,000 45%
Medical 1,250,000 1,169,000 81,000 7% 1,792,000 2,082,000 (290,000 ) (14% )
Alternative Energy 223,000 325,000 (102,000 ) (31% ) 610,000 501,000 109,000 22%
Emerging R&D and Other 400,000 516,000 (116,000 ) (22% ) 685,000 685,000 — —
Industrial 97,000 123,000 (26,000 ) (21% ) 168,000 237,000 (69,000 ) (29% )
TOTAL $ 3,346,000 $ 2,818,000 528,000 19% $ 6,168,000 $ 5,519,000 649,000 12%

	Three Months Ended										Nine Months Ended
	November 30,				Change						November 30,				Change
	2019		2018		$			%			2019		2018		$			%
Electronics/Microelectronics	$	1,104,000	$	1,034,000		70,000			7%		$	4,017,000	$	3,048,000		969,000			32%
Medical		1,083,000		644,000		439,000			68%			2,875,000		2,726,000		149,000			5%
Alternative Energy		917,000		1,061,000		(144,000	)		(14%	)		1,527,000		1,562,000		(35,000	)		(2%	)
Emerging R&D and Other		252,000		289,000		(37,000	)		(13%	)		937,000		974,000		(37,000	)		(4%	)
Industrial		316,000		127,000		189,000			148%			485,000		364,000		121,000			33%
TOTAL	$	3,672,000	$	3,155,000		517,000			16%		$	9,841,000	$	8,674,000		1,167,000			13%

Customer use of our application process development laboratories, located throughout the world, continue to reach record levels in the first ~~half~~nine months of ~~FY2020,~~fiscal 2020, which we believe demonstrates the success of our strategy to provide excellent application engineering expertise as well as paid coating services to prospects and customers to validate the capabilities of our coating technologies for their uses. These service-based customers are guided by our applications engineering team, to develop successful coating processes for their unique needs. Upon achieving coating results that meet the application requirements, the customer's next step is typically to purchase the newly defined coating solution. We believe a high percentage of prospects and customers that use our lab services to develop their products results in sales of our ultrasonic coating solutions.

~~As expected, the Alternative Energy market continued to grow in the first half of fiscal 2020 as applications and new requirements for fuel cell manufacturing equipment increased. A~~We experienced a significant increase in the Electronics/Microelectronics market, ~~was seen,~~ primarily as a result of sales to the semiconductor ~~market~~market. Sono-Tek continues to make significant investment in both personnel and equipment for ~~applying photoresist.~~focused application engineering expertise in this area.

The medical market showed ~~a decline~~an increase in the first ~~half~~nine months of fiscal 2020 which was primarily influenced by ~~a reduction in customized medical coating solutions which can~~strong sales of our equipment to be ~~highly variable quarter to quarter.~~used for stent coating.

Geographic ~~Sales~~Sales:

Three Months Ended
August 31, Change Six Months Ended
August 31, Change
2019 2018 $ % 2019 2018 $ %
U.S. & Canada $ 933,000 $ 1,068,000 (135,000 ) (13% ) $ 2,162,000 $ 2,071,000 91,000 4%
Asia Pacific (APAC) 857,000 576,000 281,000 49% 1,340,000 1,376,000 (36,000 ) (3% )
Europe, Middle East, Asia (EMEA) 883,000 922,000 (39,000 ) (4% ) 1,512,000 1,550,000 (38,000 ) (2% )
Latin America 673,000 252,000 421,000 167% 1,154,000 522,000 632,000 121%
TOTAL $ 3,346,000 $ 2,818,000 528,000 19% $ 6,168,000 $ 5,519,000 649,000 12%

	Three Months Ended November 30,				Change				Nine Months Ended November 30,				Change
	2019		2018		$		%		2019		2018		$			%
U.S. & Canada	$	1,278,000	$	1,211,000		67,000		6%	$	3,440,000	$	3,283,000		157,000			5%
Asia Pacific (APAC)		1,372,000		1,368,000		4,000		—		2,712,000		2,744,000		(32,000	)		(1%	)
Europe, Middle East, Asia (EMEA)		737,000		440,000		297,000		68%		2,249,000		1,990,000		259,000			13%
Latin America		285,000		136,000		149,000		110%		1,440,000		657,000		783,000			119%
TOTAL	$	3,672,000	$	3,155,000		517,000		16%	$	9,841,000	$	8,674,000		1,167,000			13%

In both the third quarter and first ~~half~~nine months of fiscal 2020, approximately 65% of sales originated outside of the United States and Canada compared with 62% in the ~~prior year period.~~

Inprior-year fiscal periods. The strong increase in sales to Latin America was primarily the ~~second quarter~~result of ~~fiscal 2020, approximately 72%~~a significant custom designed multi-axis medical device coating system, and a steady increase of ~~sales originated outside of the United States and Canada compared with 62% in the prior year period.~~fluxing systems sold into Mexico.

Gross Profit:

Three Months Ended
August 31, Change Six Months Ended
August 31, Change
2019 2018 $ % 2019 2018 $ %
Net Sales $ 3,346,000 $ 2,818,000 528,000 19% $ 6,168,000 $ 5,519,000 649,000 12%
Cost of Goods Sold 1,799,000 1,473,000 326,000 22% 3,316,000 2,903,000 413,000 14%
Gross Profit $ 1,547,000 $ 1,345,000 202,000 15% $ 2,852,000 $ 2,616,000 236,000 9%

Gross Profit % 46.2% 47.7% 46.2% 47.4%

For the second quarter of fiscal 2020, gross profit increased $202,000, or 15%, compared with the prior-year period. Gross profit margin was 46.2% compared with 47.7% in the second quarter of fiscal 2019.

	Three Months Ended November 30,				Change				Nine Months Ended November 30,				Change
	2019		2018		$		%		2019		2018		$		%
Net Sales	$	3,672,000	$	3,155,000	$	517,000		16%	$	9,841,000	$	8,674,000	$	1,167,000		13%
Cost of Goods Sold		1,875,000		1,859,000		16,000		1%		5,192,000		4,762,000		430,000		9%
Gross Profit	$	1,797,000	$	1,296,000	$	501,000		39%	$	4,649,000	$	3,912,000	$	737,000		19%

Gross Profit %		48.9%		41.1%						47.2%		45.1%

Gross profit increased ~~$236,000,~~$501,000, or 9%39%, to ~~$2,852,000~~$1,797,000 for the ~~first half~~third quarter of fiscal 2020 compared with ~~$2,616,000~~$1,296,000 in the prior year period. Gross profit margin was ~~46.2%~~48.9% in the third quarter of fiscal 2020, compared with ~~47.4%~~41.1% in the prior year period.

Gross profit increased $737,000, or 19%, to $4,649,000 for the first nine months of fiscal 2020 compared with $3,912,000 in the prior year period. Gross profit margin was 47.2% for the first nine months of fiscal 2020, compared with 45.1% in the prior year period.

The ~~decline~~improvement in gross profit margin for the ~~second~~third quarter and the first ~~half~~nine months of fiscal 2020, ~~reflects~~is partially due to a shift in sales to countries other than China. In the ~~change~~prior fiscal year, our gross profit margin was negatively impacted as a result of our pricing strategy to establish a foothold in ~~product mix~~the fuel cell market in China. In addition, the shift of sales away from ~~primarily OEM ultrasonic nozzles~~China, has reduced the deep discounts required to sell in China and ~~components, to larger, highly complex engineered machines with~~the avoidance of tariffs which have had a ~~higher average selling price, requiring an increase of outsourced components from~~negative impact on our ~~strategic partners.~~ margins.

In addition, in the ~~second~~third quarter and first ~~half~~nine months of fiscal 2020, ~~service department costs increased~~our gross profit margins were partially improved due to ~~the current period’s increase in volume.~~increased sales of our widetrack systems and medicoat stent coating equipment, both of these product lines traditionally have had higher profit margins compared to our other products.

Operating Expenses:

Three Months Ended
August 31, Change Six Months Ended
August 31, Change
2019 2018 $ % 2019 2018 $ %
Research and product development $ 322,000 $ 320,000 2,000 1% $ 659,000 $ 654,000 5,000 1%
Marketing and selling 799,000 697,000 102,000 15% 1,477,000 1,327,000 150,000 11%
General and administrative 334,000 314,000 20,000 6% 619,000 589,000 30,000 5%
Total Operating Expenses $ 1,455,000 $ 1,331,000 124,000 9% $ 2,755,000 $ 2,570,000 185,000 7%

	Three Months Ended November 30,				Change				Nine Months Ended November 30,				Change
	2019		2018		$		%		2019		2018		$		%
Research and product development	$	362,000	$	325,000		37,000		11%	$	1,020,000	$	979,000		41,000		4%
Marketing and selling		849,000		653,000		196,000		30%		2,326,000		1,979,000		347,000		18%
General and administrative		316,000		268,000		48,000		18%		936,000		858,000		78,000		9%
Total Operating Expenses	$	1,527,000	$	1,246,000	$	281,000		23%	$	4,282,000	$	3,816,000	$	466,000		12%

Research and Product Development:

~~The minor increases in~~For the third quarter of fiscal 2020, research and product development ~~expense~~costs increased primarily due to an increase in ~~the second quarter~~research and development materials.

For the first ~~half~~nine months of fiscal 2020, ~~were the~~research and product development costs increased $41,000 as a result of ~~increases in salaries~~higher salary expense and related health insurance ~~premiums.~~costs from the addition of personnel and increased research and development materials expense. These ~~increases~~expenses were partially offset by ~~decreased engineering materials~~decreases in depreciation and ~~supplies and depreciation~~travel expense.

Marketing and Selling:

Higher marketing and selling costs for the ~~second~~third quarter of fiscal 2020 were ~~related to~~the result of increases in salaries ~~commissions,~~and related health insurance premiums, international commission expense and ~~travel expense. These increases were partially offset by decreases in~~ trade show ~~expense and international distributor training~~ expense.

Higher marketing and selling costs for the first ~~half~~nine months of fiscal 2020 were due to increased salaries, ~~commissions,~~ health insurance premiums and trade show expense. These increases were partially offset by decreases in travel expense and international distributor training expense.

In the ~~second~~third quarter of fiscal 2020, we expended approximately ~~$175,000~~$229,000 for commissions as compared with ~~$101,000~~$116,000 for the prior year fiscal period, an increase of ~~$75,000. In~~$113,000. For the first ~~half~~nine months of fiscal 2020, we expended approximately ~~$276,000~~$505,000 for commissions as compared with ~~$209,000~~$325,000 for the prior year fiscal period, an increase of ~~$67,000.~~$180,000. The increase in commission expense, in both periods, is ~~due to~~primarily the result of an increase in ~~revenue.~~international sales being generated by our external distributors. Our external distributors are commissioned at a higher rate than our in house sales team.

General and Administrative:

Higher general and administrative costs in the ~~second~~third quarter and the first ~~half~~nine months of fiscal 2020 were the result of increases in health insurance premiums, corporate expense and stock-based compensation expense. These increases were partially offset by lower professional fees, ~~bank fees~~supplies and other miscellaneous expenses.

Health Insurance Premiums:

The Company’s health insurance program requires employee contributions. In the ~~second~~third quarter of fiscal 2020, the Company’s net health insurance expense was approximately ~~$91,000~~$94,000 as compared with ~~$73,000~~$88,000 for the prior year fiscal period, an increase of ~~$18,000~~$6,000 or ~~25%~~7%. In

For the first ~~half~~nine months of fiscal 2020, the Company’s net health insurance expense was approximately ~~$191,000~~$285,000 as compared with ~~$146,000~~$234,000 for the prior year fiscal period, an increase of ~~$45,000~~$51,000 or ~~31%~~22%. The increase in health insurance expense for the first nine months of fiscal 2020 is primarily attributable to the timing of the Company’s insurance program renewal and eligible employee enrollment.

Operating Income:

Our operating income increased ~~$78,000,~~$220,000, to ~~$92,000~~$270,000 in the ~~second~~third quarter of fiscal 2020, compared with ~~$14,000~~$50,000 for the prior year period. Growth in revenue and gross profit were key factors in the improvement of operating income in the ~~second~~third quarter of fiscal 2020. Operating margin for the quarter increased to ~~2.8%~~7.4% compared with ~~0.5%~~1.6% in the prior year period. ~~We continue to invest in our marketing and selling activities in order to expand our future market opportunities.~~

For the first ~~half~~nine months of fiscal 2020, operating income increased ~~$51,000,~~$271,000, to ~~$97,000~~$367,000 compared with ~~$46,000 for~~$96,000 in the prior year period. Growth in revenue and related growth in gross profit were key factors in the improvement of operating income in the first ~~half~~nine months of fiscal 2020. Operating margin for the first ~~half~~nine months of fiscal 2020 increased to ~~1.6%~~3.7% compared with ~~0.8%~~1.1% in the prior year period. We continue to invest in ~~our~~ research and product development, as well as marketing and selling activities as well as professional and other staffing to support our anticipated future market opportunities.

Interest Expense:

Interest expense ~~of $9,000~~was $8,000 in the ~~second~~third fiscal quarter of 2020 compared with $10,000 for the prior-year period. For the first nine months of fiscal 2020, interest expense was $25,000 compared with $31,000 for the prior year period. Interest expense ~~of $17,000 in~~is directly related to the ~~first half of 2020 compared with $21,000 for the prior year period.~~mortgage on our industrial park.

Interest and Dividend Income:

Interest and dividend income decreased ~~$11,000~~$12,000 to ~~$26,000~~$21,000 in the ~~second~~third quarter of fiscal 2020 as compared with ~~$37,000~~$33,000 for the ~~second quarter of fiscal 2019. In~~prior year period. For the first ~~half~~nine months of fiscal 2020, interest and dividend income decreased ~~$15,000~~$28,000 to ~~$57,000~~$77,000 as compared with ~~$72,000 for~~$105,000 in the ~~first half of fiscal 2019.~~prior year period. The decrease in interest and dividend income, in both periods, is due to the reallocation of our investments into US ~~treasury securities.~~Treasury securities and certificates of deposit.

Our present investment policy is to invest excess cash in highly liquid, low risk US Treasury ~~securities.~~securities, certificates of deposit and mutual funds. At ~~August 31,~~November 30, 2019, the majority of our holdings are rated at or above investment grade.

Net unrealized loss on marketable securities:

The Company adopted ASU 2016-01, “Financial Instruments – Overall: Recognition and Measurement of Financial Assets and Financial Liabilities” in the first quarter of fiscal 2019. ASU 2016-01 requires the Company to measure its equity investments at fair value and changes in fair value are to be recognized in net income. Further information is available in NOTE 2: SIGNIFICANT ACCOUNTING POLICIES in our financial statements.

In the ~~second~~third quarter and the first ~~half~~nine months of fiscal 2019, net income and earnings per share reflect the actual deduction of ~~$81,000~~$59,000 and ~~$130,000,~~$189,000, respectively, for the unrealized loss on our marketable securities.

~~For~~In the ~~second~~third quarter and the first ~~half~~nine months of fiscal 2020, there was no unrealized gain or loss recorded for the Company’s marketable securities.Our present investment policy is to invest excess cash in highly liquid, low risk US Treasury securities, certificates of deposit and mutual funds. Unrealized gains or losses, if any, are considered to be immaterial.

Other Income:

Included in other income is the net revenue related to the rental of the Company’s real estate.

For the ~~second~~third quarter of fiscal 2020, the Company’s rental revenue was $20,000, expenses were $13,000 and net revenue was $7,000. This compares with the ~~second~~third quarter of fiscal 2019 when rental revenue was ~~$23,000,~~$22,000, expenses were ~~$14,000~~$13,000 and net revenue was $9,000.

For the first ~~half~~nine months of fiscal 2020, the Company’s rental revenue was ~~$40,000,~~$60,000, expenses were ~~$28,000~~$41,000 and net revenue was ~~$12,000.~~$19,000. This compares with the first ~~half~~nine months of fiscal 2019 when rental revenue was ~~$41,000,~~$63,000, expenses were ~~$30,000~~$43,000 and net revenue was ~~$11,000.~~$20,000.

Income Tax Expense:

We recorded income tax expense of ~~$7,000~~$10,000 for the ~~second~~third quarter of fiscal 2020 ~~and fiscal 2019.~~compared with $3,000 for the prior year period.

We recorded income tax expense of ~~$13,000~~$23,000 for the first ~~half~~nine months of fiscal 2020 compared with ~~$25,000 for the first half of fiscal 2019.~~

~~Net Income:~~

~~Net income increased by $56,000 to $115,000 for the second quarter of fiscal 2020 compared with $59,000~~$28,000 for the prior year period.

Net Income:

Net income increased by ~~$59,000~~$260,000 to ~~$140,000~~$280,000 for the ~~first half~~third quarter of fiscal 2020 compared with ~~$81,000~~$20,000 for the prior fiscal period.

Net income increased by $319,000 to $420,000 for the first nine months of fiscal 2020 compared with $101,000 for the prior year period.

Fiscal Year 2020 Outlook

We expect that ~~all~~a significant portion of our backlog of ~~$4,175,000~~$5,402,000, as of ~~August 31,~~November 30, 2019, towill ship during the fiscal year ending February 29, ~~2020, supporting~~2020. However, shipments are dependent upon customer acceptance test schedules for some of our ~~expectation~~more complex and customized equipment orders. Based on our existing backlog, we expect that our current fiscal year sales will grow in the range of 15% to 25%. Furthermore, we expect that this increased sales volume will expand margins and drive stronger earnings. Part of our anticipated growth is due to a $1,650,000 order for aone of Sono-Tek’s newly ~~introduced~~developed Robotic Coating ~~Platform. This new platform~~Platforms called OMNIbot. OMNIbot is a product line that will allow us to pursue additional prospects for customers’ six-axis robotic coating needs, which presents an opportunity for ~~ongoing~~additional growth.

~~Liquidity and Capital Resources~~LIQUIDITY AND CAPITAL RESOURCES

Working Capital – Our working capital ~~decreased $28,000~~increased $272,000 to ~~$6,396,000~~$6,696,000 at ~~August 31,~~November 30, 2019 from $6,424,000 at February 28, 2019. ~~This slight decrease~~The increase in working capital was mostly the result of the current period's net income and noncash charges partially offset by purchases of equipment and repayment of long-term ~~debt partially offset by the current period's net income and noncash charges.~~debt.

The Company aggregates cash and cash equivalents and marketable securities in managing its balance sheet and liquidity. For purposes of the following analysis, the total is referred to as “Cash.” At ~~August 31,~~November 30, 2019 and February 28, 2019, our working capital included:

	August 31, 2019		February 28, 2019		Cash Increase (Decrease)			November 30, 2019		February 28, 2019		Cash (Decrease) Increase
Cash and cash equivalents	$	2,281,000	$	3,144,000	$	(863,000	)	$	2,279,000	$	3,144,000	($	865,000	)
Marketable securities		3,418,000		2,366,000		1,052,000			3,740,000		2,366,000		1,374,000
Total	$	5,699,000	$	5,510,000	$	189,000		$	6,019,000	$	5,510,000	$	509,000

The following table summarizes the accounts and the major reasons for the ~~$189,000~~$509,000 increase in “Cash”:

Impact
on Cash Reason
Accounts receivable decrease $ 125,000 Cash receipts.
Inventories increase (921,000 ) Required to support backlog.
Prepaid expenses decrease 213,000 Previous deposits on inventory.
Equipment purchases (319,000 ) Equipment upgrade for productivity.
Customer deposits increase 435,000 Received for new orders.
Accounts payable increase 347,000 Timing of disbursements.
Repayment of long-term debt (81,000 ) Repayment of debt.
Other - net 390,000 Timing of disbursements and other miscellaneous items.
Net increase in cash $ 189,000

	Impact on Cash		Reason
Net income, adjusted for non-cash items	$	841,000	To reconcile increase in cash.
Accounts receivable decrease		60,000	Cash receipts.
Inventories increase		(1,370,000)	Required to support backlog.
Prepaid expense decrease		201,000	Previous deposits on inventory.
Equipment purchases		(392,000)	Equipment upgrade for productivity.
Customer deposits increase		804,000	Received for new orders.
Accounts payable increase		469,000	Timing of disbursements.
Repayment of long-term debt		(122,000)	Repayment of debt.
Taxes payable increase		18,000	Timing of disbursements.
Net increase in cash	$	509,000

Stockholders’ Equity – ~~Stockholders’~~Stockholder’s Equity increased ~~$183,000~~$501,000 to $9,086,000 at November 30, 2019, from $8,585,000 at February 28, ~~2019 to $8,768,000 at August 31,~~ 2019. The increase iswas a result of the current period’s net income of ~~$140,000~~$420,000 and stock-based compensation expense of ~~$44,000.~~$81,000.

Operating Activities – ~~Our operating activities~~We generated ~~$589,000~~$1,023,000 of cash in our operating activities in the first ~~half~~nine months of fiscal 2020 compared with ~~using $308,000~~$88,000 in the first ~~half~~nine months of fiscal 2019. The increase in cash generated by operating activities was mostly the result of increased accounts payable, ~~and~~ accrued expenses, ~~and~~ customer deposits and a decrease in accounts receivable. These sources of cash were partially offset by increased inventories and a decrease in prepaid expenses directly related to inventory. ~~Our accounts payable and accrued expenses increased $352,000 when compared to February 28, 2019.~~

Investing Activities – For the first ~~half~~nine months of fiscal 2020, wecash used ~~$1,371,000 of cash in our~~by investing activities was $1,766,000 compared with ~~their providing $24,000~~using $361,000 of cash for the first ~~half~~nine months of fiscal 2019. For the first ~~halves~~nine months of fiscal years 2020 and 2019, we used ~~$319,000~~$392,000 and ~~$160,000,~~$487,000, respectively, for the purchase or manufacture of equipment, furnishings and leasehold improvements. For the first ~~half~~nine months of fiscal 2020, we used ~~$1,052,000~~$1,374,000 for the purchase of marketable securities and for the first ~~half~~nine months of fiscal 2019 ~~our~~we received $126,000 from the sale of marketable ~~securities provided $184,000.~~securities.

Financing Activities – In the first ~~halves~~nine months of fiscal years 2020 and 2019, we used ~~$81,000~~$122,000 and ~~$77,000,~~$117,000 in cash, respectively, for the repayment of our note payable.

Net (Decrease) in Cash and Cash Equivalents – In the first ~~half~~nine months of fiscal 2020 our cash balance decreased by ~~$863,000 as~~$865,000 compared towith a decrease of ~~$361,000~~$390,000 in the first ~~half~~nine months of fiscal 2019. In the first ~~half~~nine months of fiscal 2020, our operating activities generated ~~$589,000~~$1,023,000 of cash. In addition, we used ~~$319,000~~$392,000 for the purchase or manufacture of equipment, furnishings and leasehold improvements, used ~~$1,052,000~~$1,374,000 for the purchase of marketable securities and ~~$81,000~~used $122,000 for the repayment of our ~~notes~~note payable.

CRITICAL ACCOUNTING POLICIES

The discussion and analysis of the Company’s financial condition and results of operations are based upon the consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these financial statements requires the Company to make estimates and judgments that affect the reported amount of assets and liabilities, revenues and expenses, and related disclosure on contingent assets and liabilities at the date of the financial statements. Actual results may differ from these estimates under different assumptions and conditions.

Critical accounting policies are defined as those that are reflective of significant judgments and uncertainties, and may potentially result in materially different results under different assumptions and conditions. The Company believes that critical accounting policies are limited to those described below. For a detailed discussion on the application of these and other accounting policies see Note 2 to the Company’s consolidated financial statements included in Form 10-K for the year ended February 28, 2019.

Accounting for Income Taxes

As part of the process of preparing the Company’s condensed consolidated financial statements, the Company is required to estimate its income taxes. Management judgment is required in determining the provision for the deferred tax asset.

Stock-Based Compensation

The computation of the expense associated with stock-based compensation requires the use of a valuation model. ASC 718 is a complex accounting standard, the application of which requires significant judgment and the use of estimates, particularly surrounding Black-Scholes assumptions such as stock price volatility, expected option lives, and expected option forfeiture rates, to value equity-based compensation. The Company currently uses a Black-Scholes option pricing model to calculate the fair value of its stock options. The Company primarily uses historical data to determine the assumptions to be used in the Black-Scholes model and has no reason to believe that future data is likely to differ materially from historical data. However, changes in the assumptions to reflect future stock price volatility and future stock award exercise experience could result in a change in the assumptions used to value awards in the future and may result in a material change to the fair value calculation of stock-based awards. ASC 718 requires the recognition of the fair value of stock compensation in net income. Although every effort is made to ensure the accuracy of our estimates and assumptions, significant unanticipated changes in those estimates, interpretations and assumptions may result in recording stock option expense that may materially impact our financial statements for each respective reporting period.

IMPACT OF NEW ACCOUNTING PRONOUNCEMENTS

For information regarding new accounting pronouncements and their effect on the Company, see “New Accounting Pronouncements” in Note 2 of the unaudited notes to the condensed consolidated financial statements.

ITEM 3 - Quantitative and Qualitative Disclosures about Market Risk

The Company does not issue or invest in financial instruments or derivatives for trading or speculative purposes. Substantially all of the operations of the Company are conducted in the United States, and, as such, are not subject to material foreign currency exchange rate risk. All of our sales transactions are completed in US dollars.

Although the Company's assets included ~~$2,281,000~~$2,279,000 in cash and ~~$3,418,000~~$3,740,000 in marketable securities, the market rate risk associated with changing interest rates in the United States is not material.

ITEM 4 – Controls and Procedures

The Company has established and maintains “disclosure controls and procedures” (as those terms are defined in Rules 13a –15(e) and 15d-15(e) under the Securities and Exchange Act of 1934 (the “Exchange Act”). Christopher L. Coccio, Chief Executive Officer (principal executive) and Stephen J. Bagley, Chief Financial Officer (principal accounting officer) of the Company, have evaluated the Company’s disclosure controls and procedures as of ~~August 31,~~November 30, 2019. Based on this evaluation, they have concluded that the Company’s disclosure controls and procedures were effective to ensure that information required to be disclosed by the Company in reports that it files or submits under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (2) accumulated and communicated to Management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding timely disclosure.

In addition, there were no changes in the Company’s internal controls over financial reporting during the ~~second~~third fiscal quarter of 2020 that have materially affected, or are reasonably likely to materially affect, internal controls over financial reporting.

PART II - OTHER INFORMATION

Item 1.	Legal Proceedings
	None

Item 1A.	Risk Factors
	Note Required for Smaller Reporting Companies

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.
	None

Item 3.	Defaults Upon Senior Securities
	None

Item 4.	Mine Safety Disclosures
	None

Item 5.	Other Information
	None

Item 6.	Exhibits and Reports

	31.1 –31.2– Rule 13a - 14(a)/15d – 14(a) Certification

	32.1 –32.2 – Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to section 906 of the Sarbanes-Oxley Act of 2002.

	101.INS – XBRL Instance Document.

	101.SCH – XBRL Taxonomy Extension Schema Document

	101.CAL – XBRL Taxonomy Calculation Linkbase Document

	101.DEF – XBRL Taxonomy Extension Definition Linkbase Document

	101.LAB – XBRL Extension Label Linkbase Document

	101.PRE – XBRL Taxonomy Extension Presentation Linkbase Document

SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: ~~October 15, 2019~~

January 14, 2020

		SONO-TEK CORPORATION
		(Registrant)


	By:	/s/ Christopher L. Coccio
		Christopher L. Coccio
		Chief Executive Officer



	By:	/s/ Stephen J. Bagley
		Stephen J. Bagley
		Chief Financial Officer

New York	14-1568099
(State or other jurisdiction of	(IRS Employer
incorporation or organization)	Identification No.)

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
None	N/A	N/A

Large Accelerated Filer☐	Accelerated Filer☐
Non-Accelerated Filer☐	Smaller reporting company☑
	Emerging Growth company☐

		Outstanding as of ~~October 12, 2019~~January 14, 2020
Class
Common Stock, par value $.01 per share	~~15,301,613~~		15,323,831

	Common Stock Par Value $.01				Additional Paid – In			Accumulated Other Comprehensive			Accumulated			Total Stockholders’
	Shares		Amount		Capital			Income (Loss)			Deficit			Equity
Balance – February 28, 2018		14,986,367	$	149,864	$	8,901,171		$	101,605		$	(760,115	)	$	8,392,525
Reclassification of unrealized gain on marketable securities upon adoption of ASU 2016-01									(101,605	)		101,605			—
Cashless exercise of stock options		169,193		1,692		(1,692	)								—
Stock based compensation expense						16,394									16,394
Net Income												80,554			80,554
Balance – August 31, 2018 (Unaudited)		15,155,560	$	151,556	$	8,915,873		$	—		$	(577,956	)	$	8,489,473

	Impact on Cash			Reason
Accounts receivable decrease	$	125,000		Cash receipts.
Inventories increase		(921,000	)	Required to support backlog.
Prepaid expenses decrease		213,000		Previous deposits on inventory.
Equipment purchases		(319,000	)	Equipment upgrade for productivity.
Customer deposits increase		435,000		Received for new orders.
Accounts payable increase		347,000		Timing of disbursements.
Repayment of long-term debt		(81,000	)	Repayment of debt.
Other - net		390,000		Timing of disbursements and other miscellaneous items.
Net increase in cash	$	189,000